Stocks
Evolent Health (EVH) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -245.9 | -241.4 | 55.7 | 43.7 | -24.8 | 63.0 | ||
| Changes by years, y/y, % | +2 879% | -2% | -123% | -21% | -157% | +24.6% | |||
Evolent Health. EBITDA US GAAP, bln rub
Evolent Health. EBITDA US GAAP, changes, %
Evolent Health. EBITDA US GAAP, sum by quarters, bln rub
Evolent Health (EVH) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -6.23 | 18.8 | 40.4 | -8.16 | 12.0 | 63.0 | |
| Changes by years, y/y, % | +263% | -150% | +47% | -144% | -35% | |||
| Changes by quarters, q/q, % | -134% | -402% | +115% | -120% | -247% | |||
